BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1360873)

  • 1. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells.
    Hegmann EJ; Bauer HC; Kerbel RS
    Cancer Res; 1992 Dec; 52(24):6969-75. PubMed ID: 1360873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional expression and localization of P-glycoprotein at the blood brain barrier.
    Bendayan R; Lee G; Bendayan M
    Microsc Res Tech; 2002 Jun; 57(5):365-80. PubMed ID: 12112443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P glycoprotein regulated transport of glutamate at blood brain barrier.
    Liu XD; Liu GQ
    Acta Pharmacol Sin; 2001 Feb; 22(2):111-6. PubMed ID: 11741514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
    Gollapudi S; Gupta S
    Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 Jul; 23(7):591-6. PubMed ID: 12100750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B; Prichard RK; Georges E
    Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
    Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
    Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K; Tsuruo T
    Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.
    Yang ZY; Liu GQ
    Pharmazie; 2004 Dec; 59(12):952-6. PubMed ID: 15638085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
    Murata M; Tamai I; Kato H; Nagata O; Tsuji A
    J Pharmacol Exp Ther; 1999 Jul; 290(1):51-7. PubMed ID: 10381759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased P-glycoprotein function and level after long-term exposure of four antiepileptic drugs to rat brain microvascular endothelial cells in vitro.
    Yang HW; Liu HY; Liu X; Zhang DM; Liu YC; Liu XD; Wang GJ; Xie L
    Neurosci Lett; 2008 Apr; 434(3):299-303. PubMed ID: 18313849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells.
    Tatsuta T; Naito M; Mikami K; Tsuruo T
    Cell Growth Differ; 1994 Oct; 5(10):1145-52. PubMed ID: 7848916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
    Kavallaris M; Madafiglio J; Norris MD; Haber M
    Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active transport of fentanyl by the blood-brain barrier.
    Henthorn TK; Liu Y; Mahapatro M; Ng KY
    J Pharmacol Exp Ther; 1999 May; 289(2):1084-9. PubMed ID: 10215691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
    Van Acker KL; Van Hove LM; Boogaerts MA
    Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the multidrug resistance of P-glycoprotein in healthy tissues: the example of the blood-brain barrier.
    Lechardeur D; Phung-Ba V; Wils P; Scherman D
    Ann Biol Clin (Paris); 1996; 54(1):31-6. PubMed ID: 8731793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional modulation of ATPase of P-glycoprotein by C219, a monoclonal antibody against P-glycoprotein.
    Kokubu N; Cohen D; Watanabe T
    Biochem Biophys Res Commun; 1997 Jan; 230(2):398-401. PubMed ID: 9016791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.